NEUROFIBROMATOSIS TYPE 2
Clinical trials for NEUROFIBROMATOSIS TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS TYPE 2 trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for controlling rare genetic tumors
Disease control OngoingThis study is testing two repurposed cancer drugs, brigatinib and neratinib, to see if they can slow or stop the growth of tumors in people with NF2-related schwannomatosis. It will enroll about 100 participants aged 12 and older who have specific, growing tumors. The trial uses …
Matched conditions: NEUROFIBROMATOSIS TYPE 2
Phase: PHASE2 • Sponsor: Scott R. Plotkin, MD, PhD • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Early trial tests new drug mixes for Tough-to-Treat cancers
Disease control OngoingThis early-stage trial aims to find safe doses and understand side effects of several drug combinations for patients with advanced cancers that haven't responded to standard treatments. The study involves 155 participants with various advanced or metastatic cancers and some rare …
Matched conditions: NEUROFIBROMATOSIS TYPE 2
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Needle instead of knife? simple injection could shrink painful NF2 tumors
Disease control OngoingThis study is testing whether injecting an antibiotic called doxycycline directly into skin tumors can shrink them in people with Neurofibromatosis Type 2 (NF2). The goal is to find a simpler, less risky alternative to surgical removal. Researchers are measuring tumor size change…
Matched conditions: NEUROFIBROMATOSIS TYPE 2
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC